For vaccination against meningococcal group B disease (MenB), it’s important to complete all doses of TRUMENBA.

When you enroll in TRU NextDose, we’ll send you helpful reminders on when to schedule your teen’s next vaccination.

Get Started

As a parent or caregiver enrolling in the TRU NextDose Reminder Program, please select which types of reminder messages you would like to receive. Once enrolled, participants will receive automated reminder communications, including next appointment reminder messages and other health information.

Enrollment in the TRU NextDose Reminder Program is available only to parents or caregivers. To participate in the TRU NextDose Reminder Program, parents or caregivers must provide their mobile phone number to receive text reminders (required). Phone call and email reminders are optional.

All fields are required unless marked optional.

By providing your phone number, you consent to receive autodialed non-marketing texts from Pfizer and its service providers regarding TRU NextDose Reminder Program at the phone number provided. You will receive a text asking you to confirm your receipt. Up to 6 messages/month. Message and data rates may apply. Privacy Policy at:

See full terms at . For help, text HELP to (724) 605-4705. To opt-out, text STOP to (724) 605-4705 (a confirmation text will be sent).

Call Me (Optional)

Mobile Terms and Conditions: By enrolling, you agree to receive autodialed text messages and autodialed phone calls (if selected) from or on behalf of Pfizer at the telephone number(s) that you provide. You understand that this is not a condition of purchase or use of TRUMENBA or of any Pfizer product or service. See full terms at .

  • There is no fee payable to Pfizer to receive text messages or phone calls; however, your carrier’s message and data rates may apply.
  • Data obtained from you in connection with your registration for, and use of, this service may include your phone number, related carrier information, and will be used to administer this program and to provide program benefits such as dosing reminders, program updates, and alerts.
  • Pfizer will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your network operator.
  • Pfizer reserves the right to rescind, revoke, or amend the TRU NextDose Program without notice at any time.
  • You may receive up to 6 messages a month. Pfizer’s privacy policy is available at You may unsubscribe from the Program at any time by texting STOP to (724) 605-4705. For help, text HELP.

Pfizer understands that your personal and health information are private. The information you provide will only be used by Pfizer and parties acting on its behalf to send you the materials you requested and other helpful information and updates on TRUMENBA.

Visit Information

The below fields are required to ensure that reminder messages are provided according to the appropriate dosing schedule. Please provide the dosing schedule provided by your teen's health care provider, and the date and location of first vaccination.

Date of dose 1 cannot be more than 30 days before registration

Choose the dosing schedule recommended by your teen's health care provider or pharmacist. Healthy teens are recommended to follow the two-dose schedule.


  • Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B


  • Trumenba should not be given to anyone with a history of a severe allergic reaction to any component of Trumenba
  • Some individuals with weakened immune systems may have a reduced immune response
  • Persons with certain complement deficiencies and persons receiving treatments such as Soliris® (eculizumab), are at increased risk for invasive disease caused by Neisseria meningitidis group B even with receipt of vaccination with Trumenba
  • Vaccination with Trumenba may not protect all vaccine recipients against N meningitidis group B infections
  • Fainting can occur in association with administration of injectable vaccines, including Trumenba
  • The most common adverse reactions in adolescents and young adults were pain at injection site, fatigue, headache, and muscle pain
  • Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series
  • Tell your health care provider if you are pregnant, or plan to become pregnant
  • Ask your health care provider about the risks and benefits of Trumenba. Only a health care provider can decide if Trumenba is right for you or your child

Please see full Prescribing Information